Diacomit

BIOCODEX, INC.🇺🇸 United States

FDA Page

Effective Date: Jul 24, 2022
Approval ID: 58304ba8-9779-4658-811e-94ffe08c3f16
Products: 4 registered
Version: 5

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DIACOMIT safely and effectively. See full prescribing information for DIACOMIT. DIACOMIT (stiripentol) capsules, for oral use DIACOMIT (stiripentol) for oral suspension Initial U.S. Approval: 2018

Quick Stats

Total Products4

Labelers2

Label Sections38

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.